StonvexLoading…
StonvexStonvexStonvexCore line items from DTCX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.96M | $741.00 | $2.05K | $2.42K |
Operating Income | $-7.92M | $-3.95M | $-2.52M | $-1.21M |
Net Income | $-8.50M | $-4.00M | $-3.32M | $-1.50M |
EPS (Diluted) | $-0.46 | $-0.50 | $-0.47 | $-0.24 |
Total Assets | $66.84M | $5.10M | $415.19K | $1.16M |
Total Liabilities | Not available | $335.20K | $65.86K | $374.27K |
Cash & Equivalents | $38.92M | $4.68M | $259.21K | $1.16M |
Free Cash Flow OCF − CapEx | $-32.39M | $-3.50M | $-2.33M | Not available |
Shares Outstanding | 30.38M | 9.40M | 7.66M | 7.11M |